Home
Dashboard
French Tech Next40/120
French Tech 2030
Curated content

Companies
Job board
Investors
Funding rounds
Exits

Universities
Accelerators
Workspaces
Service providers
More organizations

Investment heatmap
Themes

Powered by

La French Tech

Contact
FAQ
Privacy

Companies
Fusion Pharmaceuticals
Team
Team

Fusion Pharmaceuticals

Targeted alpha therapeutics (TAT) for the treatment of chemotherapy resistant cancers. Learn more

Launch date

2014

Employees

Market cap

€1.7b

Enterprise valuation

€1.5b (Public information from May 2024)

Share price

$21.55 FUSN

Hamilton Ontario (HQ)

http://fusionpharma.com/

https://twitter.com/fusionpharmainc https://www.linkedin.com/company/fusion-pharmaceuticals

View job openings

B2B
manufacturing
health
biotechnology

hard tech
biotechnology
biotech and pharma
oncology
verified unicorns and $1b exits
post ipo $1b
chemotherapy

Authorizing premium user...